MCL exhibits a complex pathobiology that includes cyclin D1 overexpression, abnormalities in the DNA damage response, and dysregulation of the PI3K/Akt and NF-κB cell survival pathways [1, 17]. This evidence concerns the gene AKT1 and mantle cell lymphoma.